Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02553447
What this trial is testing

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin LymphomaUntreated Chronic Lymphocytic Leukemia+1 more
University of Nebraska 197
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT01344876
What this trial is testing

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaAcute Myeloid Leukemia+2 more
Otsuka Pharmaceutical Co., Ltd. 20
Not applicableStudy completedNCT03935282
What this trial is testing

Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors

Who this might be right for
Breast NeoplasmProstatic NeoplasmColorectal Neoplasms+3 more
Wake Forest University Health Sciences 645
Testing effectiveness (Phase 2)Ended earlyNCT00183950
What this trial is testing

Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
University of Southern California 12
Testing effectiveness (Phase 2)Study completedNCT00822120
What this trial is testing

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Who this might be right for
LymphomaNonneoplastic Condition
SWOG Cancer Research Network 371
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT05502250
What this trial is testing

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

Who this might be right for
Hodgkin Lymphoma
Stichting Hemato-Oncologie voor Volwassenen Nederland 75
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Early research (Phase 1)Study completedNCT03357627
What this trial is testing

TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Large B-cell, DiffuseLymphoma, Follicular
Calithera Biosciences, Inc 43
Testing effectiveness (Phase 2)Study completedNCT00491127
What this trial is testing

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Eli Lilly and Company 10
Testing effectiveness (Phase 2)Study completedNCT00742027
What this trial is testing

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin's Lymphoma
Novartis Pharmaceuticals 129
Not applicableStudy completedNCT03860376
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+11 more
Florida International University 25
Not applicableWithdrawnNCT05169151
What this trial is testing

Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study

Who this might be right for
Central Nervous System NeoplasmHodgkin LymphomaMalignant Solid Neoplasm+2 more
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00036946
What this trial is testing

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT03697408
What this trial is testing

Itacitinib + Everolimus in Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
University of Pennsylvania 23
Early research (Phase 1)Study completedNCT02529813
What this trial is testing

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaBlasts 5 Percent or More of Bone Marrow Nucleated Cells+6 more
M.D. Anderson Cancer Center 26
Early research (Phase 1)Study completedNCT00990717
What this trial is testing

Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
University Health Network, Toronto 8
Not applicableStudy completedNCT00333190
What this trial is testing

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic MalignancyAMLALL+4 more
Dana-Farber Cancer Institute 30
Next Page